John Mascarenhas, MD, discusses the rationale, mechanism, and design of the phase 1 INCA33989-101 and -102 trials investigating a CAL-R–targeted antibody for patients with essential thrombocythemia.

Two new Omicron subvariants are gaining ground in the U.S. as some people report experiencing respiratory symptoms like ...

Now, scientists say the woman is the only known carrier of a new blood type called “Gwada negative.” It’s the only blood type ...

NanoBio Designs, Integrated Dynamics, and NutriPop scoop the top prizes in an innovation accelerator run by AgriNovus Indiana ...

Now, local doctors have developed a new rapid test for valley fever that can detect the infection in just 10 minutes. They say it will help you get the right treatment faster. The average time to ...

Arizona doctors said the average time to diagnose a patient with valley fever is close to three weeks but with this new test, they can find out in just minutes. Valley fever is a lung infection caused ...